CD68 and metabolic dysfunction-associated steatohepatitis: Quantitative analysis also revealed that the number of CD68/CD206/Gal-3+ macrophages was significantly reduced in patients with steatosis and exhibited a trend of decrease in NASH (Figure 3C,D).